Abstract
Today, monoclonal antibodies (mAbs) form the largest category of biopharmaceuticals in clinical trials and their number is expanding rapidly (DataMonitor 2007). The antibodies or functional antibody fragments are being produced in artificial production systems like mammalian cells, yeast, bacteria and plant cells but also in transgenic animals like goats, sheep and cows. Regardless of the production method, the quality control demand is the same for all of them. Host cell proteins, cell culture media additives, DNA and endotoxins have to be removed from the mAb preparation to allow the proteins to be safely applied for human therapy. Moreover, antibody aggregates, clipped and low molecular weight species should also be removed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Åkerström B, Björk L (1989) Protein L: an immunoglobulin light chain binding bacterial protein. J Biol Chem 264:19740–19746
Bergmann-Leitner ES, Mease RM, Duncan EH, Khan F, Waitumbi J, Angov E (2008) Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies. Malar J 7:129–139
Björk L, Kronvall G (1984) Purification and some properties of Streptococcal protein G a novel IgG-binding reagent. J Immunol 133:969–974
Boi C, Dimartino S, Sarti GC (2008) Performance of a new protein A affinity membrane for the primary recovery of antibodies. Biotech Prog 24:640–647
Bonifacino JS, Dell’Angelica EC (1998) Immunoprecipitation. Curr Protoc Cell Biol Chapter 7:7.2.1–7.2.21
Carter-Franklin JN, Victa C, McDonald P, Fahrner R (2007) Fragments of protein A eluted during protein A chromatography. J Chromatog A 1163:105–111
Cossins AJ, Harrison S, Popplewell AG, Gore MG (2007) Recombinant production of a VL single domain antibody in Escherichia coli and analysis of its interaction with peptostreptococcal protein L. Protein Expr Purif 51:253–259
Das D, Allen TM, Suresh MR (2005) Comparative evaluation of two purification methods of anti-CD19-c-myc-His6-Cys scFv. Protein Expr Purif 39:199–208
DataMonitor (2007) Monoclonal Antibodies Report Market Model – Detailed analysis of the monoclonal antibody segment, encompassing market dynamics, key therapy areas, technology and target types through to 2012, evaluating the strategies companies are using to capitalize on this lucrative market. Reference Code: IMHC0090, June 2007
DataMonitor (2007) Monoclonal Antibodies Report Part 1. Reference Code: DMHC2291, June 2007
De Château M, Nilson BH, Erntell M, Myhre E, Magnusson CG, Akerström B, Björck L (1993) On the interaction between protein L and immunoglobulins of various mammalian species. Scand J Immunol 37:339–405
Devaux C, Moreau E, Goyffon M, Rochat H, Billiald P (2001) Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector. Eur J Biochem 268:694–702
Eliasson M, Olsson A, Palmcrantz E, Wiberg K, Inganäs M, Guss B, Lindberg M, Uhlén M (1988) Chimeric IgG-binding receptors engineered from staphylococcal protein A and streptococcal protein G. J Biol Chem 263:4323
Enever C, Tomlinson IA, Lund J, Levens M, Holliger P (2005) Engineering high affinity superantigens by phage display. J Mol Biol 347:107–120
Fahrner RL, Whitney DH, Vanderlaan M, Blank GS (1999) Performance comparison of protein A affinity-chromatography sorbents for purifying recombinant monoclonal antibodies. Biotechnol Appl Biochem 30:121–128
Forsgren A, Sjöquist J (1966) Protein A from staphylococcus Aureus I Pseudoimmune reaction with human gamma-globulin. J Immunol 97:822–827
Fuglistaller P (1989) Comparison of immunoglobulin binding capacities and ligand leakage using eight different protein A affinity chromatography matrices. J Immunol Methods 124:171–177
Ghose S, Allen M, Hubbard B, Brooks C, Cramer SM (2005) Antibody variable region interactions with protein A: Implications for the development of generic purification process. Biotechnol Bioeng 92:665–673
Ghose S, Hubbard B, Cramer SM (2007) Binding capacity differences for antibodies and Fc-Fusion proteins on protein A chromatographic materials. Biotechnol Bioeng 96:768–779
Godfrey MA, Kwasowsky P, Clift R, Marks V (1993) Assessment of the suitability of commercially available SpA affinity solid phases for the purification of murine monoclonal antibodies at process scale. J Immunol Methods 160:97–105
Gülich S, Linhult M, Stål S, Hober S (2002) Engineering streptococcal protein G for increased alkaline stability. Prot Eng 15:835–842
Hahn R, Schlegel R, Jungbauer A (2003) Comparison of protein A affinity sorbents. J Chromatog B 790:35–51
Hahn R, Shimahara K, Steindl F, Jungbauer A (2006) Comparison of protein A affinity sorbents III Life time study. J Chromatog A 1102:224–231
Harrison SL, Housden NG, BottomLey SP, Cossins AJ, Gore MG (2008) Generation of a minimal hybrid Ig-receptor formed between single domains from proteins L and G. Protein Expr purif 58:12–22
Hober S, Nord K, Linhult M (2007) Protein A chromatoghraphy for antibody purification. J Chromatog B 848:40–47
Holt LJ, Basran A, Jones K, Chorlton J, Jespers LS, Brewis ND, Tomlinson IM (2008) Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs. Prot Eng Des Sel 21:283–288
Housden NG, Harrison S, Roberts SE, Beckingham JA, Graille M, Stura E, Gore MG (2003) Immunoglobulin-binding domains: Protein L from peptostreptococcus magnus. Biochem Soc Trans 31:716–718
Housden NG, Harrison S, Housden HR, Thomas KA, Beckingham JA, Roberts SE, Bottomley SP, Graille M, Stura E, Gore MG (2004) Observation and characterization of the interaction between a single immunoglobulin binding domain of protein L and two equivalents of human κ light chains. J Biol Chem 279:9370–9378
Kastern K, Sjöbring U, Björk L (1992) Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain. J Bio Chem 267:12820–12825
Katoh S, Imada M, Takeda N, Katsuda T, Miyahara H, Inoue M, Nakamura S (2007) Optimization of silica-based media for antibody purification by protein A affinity chromatography. J Chromatog A 1161:36–40
Kihlberg B, Sjöholm AG, Björk L, sjöbring U (1996) Characterization of the binding properties of protein LG, an immunoglobulin binding hybrid protein. Eur J Biochem 240:556–563
Kim JY, Mulchandani A, Chen W (2005) Temperature-triggered purification of antibodies. Biotechnol Bioeng 90:373–379
LeVan MD, Carta G, Yon CM (1997) Adsorption and ion exchange In: Green DW (ed), Perry’s Chemical engineers Handbook, 7th edn. McGraw-Hill, New York, Chapter 16
Linhult M, Gülich S, Gräslund T, Simon A, Karlsson M, Sjöberg A, Nord K, Hober (2004) Improving the tolerance of a protein A analogue to repeated alkaline phosphatase exposures using a bypass mutagenesis approach. Proteins: structure, function, and bioinformatics 55:407–416
Løset GÅ, Løbersli I, Kavlie K, Stacy JE, Borgen T, Kausmally L, Hvattum E, Simonsen B, Befring Hovda M, Brekke OH (2005) Construction, evaluation and refinement of a large human antibody phage library based on the IgD and IgM variable gene repertoire. J Immunol Methods 299:47–62
Nilson BHK, Solomon A, Björk L, Åkerström B (1992) Protein L from peptostreptococcus magnus binds to the κ light chain variable domain. J Biol Chem 267:2234–2239
Shukla AA, Gupta P, Han X (2007) Protein aggregation kinetics during protein A chromatography, a case study for an Fc fusion protein. J Chromatog A 1171:22–28
Sletta H, Nedal A, Aune TE, Hellebust H, Hakvåg S, Aune R, Ellingsen TE, Valla S, Brautaset T (2004) Broad-host-range plasmid pJB658 can be used for industrial-level production of a secreted host-toxic single-chain antibody fragment in Escherichia coli. Appl Environ Microbiol 70:7033–9039
Solomon A (1976) Bence-Jones proteins and light chains of immunoglobulins. N Engl J Med 294:17–23
Starovasnik MA, O’Connell MP, Fairbrother WJ, Kelley RF (1999) Antibody variable region binding by staphylococcal protein A: Thermodynamic analysis and location of the Fv binding site on E-domain. Prot Sci 8:1423–1431
Svensson H, Hoogenboom HR, Sjöbring U (1998) Protein LA, a novel hybrid protein with unique single-chain Fv antibody and Fab binding properties. Eur J Biochem 258:890–896
Swinnen K, Krul A, Van Goidsenhoven I, Van Tichelt N, Roosen A, Van Houdt K (2007) Performance comparison of protein A affinity resins for the purification of monoclonal antibodies. J Chromatog B 848:97–107
Tugcu N, Roush DJ, Göklen KE (2007) Maximizing productivity of chromatography steps for purification of monoclonal antibodies. Biotechnol Bioeng 99:599–613
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this protocol
Cite this protocol
Griep, R., McDougall, J. (2010). Analysis and Purification of Antibody Fragments Using Protein A, Protein G, and Protein L. In: Kontermann, R., Dübel, S. (eds) Antibody Engineering. Springer Protocols Handbooks. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01147-4_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-01147-4_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01146-7
Online ISBN: 978-3-642-01147-4
eBook Packages: Springer Protocols